SCHEMBL5380764

SCHEMBL5380764

Cc1ccc(S(=O)(=O)Nc2ccc(SCc3nc4cc(C(F)(F)F)ccc4s3)cc2)cc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 3/20 0.57
POLB P06746 1/20 0.45
AKR1B1 P15121 6/20 0.41
PPARA Q07869 1/20 0.41
GFER P55789 1/20 0.40
AKR1A1 P14550 1/20 0.39
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NOD2 Q9HC29 1/20 0.38
HSD17B2 P37059 1/20 0.38
CASP6 P55212 1/20 0.38
DYRK1A Q13627 1/20 0.38
ALOX5 P09917 1/20 0.38
GPR27 Q9NS67 2/20 0.38
AVPR2 P30518 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5391125 0.92 TRPV1 (0.56) TRPV1POLBAKR1B1PPARAAKR1A1
SCHEMBL5376865 0.89 POLB (0.47) TRPV1POLBGFERLMNAPKM
SCHEMBL5370583 0.87 POLB (0.48) TRPV1POLBGFERLMNAPKM
SCHEMBL5371856 0.82 POLB (0.53) POLBPPARAGFERSMN1; SMN2CASP6
SCHEMBL5378671 0.81 TRPV1 (0.45) TRPV1POLBLMNAPKMHTT
SCHEMBL5373210 0.81 POLB (0.50) POLBGFERLMNAHTTSMN1; SMN2
SCHEMBL4897642 0.81 TRPV1 (0.50) TRPV1AKR1B1AKR1A1LMNADYRK1A
SCHEMBL5380661 0.80 POLB (0.46) TRPV1POLBAKR1B1GFERLMNA
SCHEMBL5373144 0.80 POLB (0.53) POLBGFERSMN1; SMN2HSD17B2CASP6
SCHEMBL27660093 0.80 TRPV1 (0.49) TRPV1POLBLMNAPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TRPV1 3397/4885POLB 1807/4885AKR1B1 1224/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD TRPV1 3257/4885POLB 2006/4885AKR1B1 1111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.